Chất lượng cuộc sống liên quan đến sức khỏe ở bệnh nhân mắc hội chứng đau myofascial

Quality of life and clinical trials. Lancet 1995, 346:1–2. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 1994, 272:619–626. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995, 41:1403–1409. Khanna D, Tsevat J: Health-related quality of life: an introduction. Am J Manag Care 2007, 13(Suppl 9):S218–S223. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993, 118:622–629. Burckhardt CS, Anderson KL: The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 2003, 1:60. Ware JE Jr, Sherbourne CD: The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473–483. McCallum J: The SF 36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health 1995, 19:160–166. McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247–263. Bullinger M, Alonso J, Apolone G, et al.: Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:913–923. Perneger TV, Leplège A, Etter JF: Cross-cultural adaptation of a psychometric instrument: two methods compared. J Clin Epidemiol 1999, 52:1037–1046. Wagner AK, Gandek B, Aaronson NK, et al.: Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:925–932. Ware JE Jr, Kosinski M, Bayliss MS, et al.: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995, 33:AS264–AS279. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40–66. Bruce B, Fries JF: The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003, 30:167–178. Hunt SM, McEwen T: The development of a subjective health indicator. Sociol Health Illn 1980, 2:231–246. Simons DG, Travell JG, Simons LS, et al.: Travell & Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual, vol 1, edn 2. Baltimore, MD: Lippincott Williams & Wilkins; 1999:132. Borg-Stein J, Simons DG: Focused review: myofascial pain. Arch Phys Med Rehabil 2002, 83(3 Suppl 1):S40–S47, S48–S49. Lavelle ED, Lavelle W, Smith HS: Myofascial trigger points. Med Clin North Am 2007, 91:229–239. Han SC, Harrison P: Myofascial pain syndrome and trigger-point management. Reg Anesth 1997, 22:89–101. Graff-Radford SB: Myofascial pain: diagnosis and management. Curr Pain Headache Rep 2004, 8:463–467. Thumboo J, Strand V: Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singapore 2007, 36:115–122. Hoffman DL, Dukes EM: The health status burden of people with fibromyalgia: a review of studies that assessed health status with SF-36 or the SF-12. Int J Clin Pract 2008, 62:115–126. Bal S, Çeliker R: Health-related quality of life in patients with myofascial syndrome: a controlled clinical study. J Musculoskel Pain 2009, 17:173–177. Tüzün EH, Albayrak G, Eker L, et al.: A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome. Disabil Rehabil 2004, 26:198–202. Eyigör S, Ozdedeli S, Durmaz B: The prevalance of generalized soft tissue rheumatic conditions in Turkish medical students. J Clin Rheumatol 2008, 14:65–68. Sahin N, Karataş O, Ozkaya M, et al.: Demographic features, clinical findings and functional status in a group of subjects with cervical myofascial pain syndrome. Agri 2008, 20:14–19. Irnich D, Behrens N, Molzen H, et al.: Randomised trial of acupuncture compared with conventional massage and “sham” laser acupuncture for treatment of chronic neck pain. BMJ 2001, 322:1574–1578. Fransen J, van Riel PL: Outcome measures in inflammatory rheumatic diseases. Arthritis Res Ther 2009, 11:244. Kosinski M, Keller SD, Ware JE Jr, et al.: The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999, 37(5 Suppl):MS23–MS39. Kiltz U, van der Heijde D: Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis. Clin Exp Rheumatol 2009, 27(4 Suppl 55):S108–S111. Laas K, Roine R, Räsänen P, et al.: Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 2009, 29:267–273. Salaffi F, Sarzi-Puttini P, Girolimetti R, et al.: Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 2009, 27:S67–S74. Elliott TE, Renier CM, Palcher JA: Chronic pain, depression, and quality of life: correlations and predictive value of SF-36. Pain Med 2003, 4:331–339. •• Börsbo B, Peolsson M, Gerdle B: The complex interplay between pain intensity, depression, anxiety and catastrophising with respect to quality of life and disability. Disabil Rehabil 2009, 31:1605–1613. This study highlights the interaction between psychological factors, pain, and quality of life in patients with chronic pain. • Birtane M, Uzunca K, Taştekin N, Tuna H: The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol 2007, 26:679–684. This study emphasizes that musculoskeletal conditions such as fibromyalgia syndrome lead to deterioration in quality of life comparable to rheumatoid arthritis. Tander B, Cengiz K, Alayli G, et al.: A comparative evaluation of heath related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol Int 2008, 28:859–865. Ge HY, Nie H, Madeleine P, et al.: Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain 2009, 147:233–240. Lew HL, Lee EH, Castaneda A, et al.: Therapeutic use of botulinum toxin type A in treating neck and upper back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 2008, 89:75–80. Yoon SH, Rah UW, Sheen SS, Cho KH: Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial. Arch Phys Med Rehabil 2009, 90:1332–1339. Kamanlı A, Kaya A, Ardicoglu O, et al.: Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005, 25:604–611. Gur A, Sarac AJ, Cevik R, et al.: Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: a double-blind and randomize-controlled trial. Lasers Surg Med 2004, 35:229–235. Affaitati G, Fabrizio A, Savini A, et al.: A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther 2009, 31:705–720.